LPL Financial
GILD icon

LPL Financial’s Gilead Sciences GILD Stock Holding History

LPL Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,400
Closed -$334K – 6266
2026
Q1 		$334K Buy
+2,400
New +$336K ﹤0.01% 5117
2025
Q3 		– Sell
-2,200
Closed -$244K – 5879
2025
Q2 		$244K Sell
2,200
-1,000
-31% -$106K ﹤0.01% 4936
2025
Q1 		$359K Buy
+3,200
New +$330K ﹤0.01% 4458

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial's GILD Position: Q2 2026 in Review

LPL Financial reduced its Gilead Sciences (GILD) stake by 4.1% in Q2 2026, selling an estimated $5.5M and leaving 969,813 shares worth $123M. The position accounts for 0.03% of the portfolio, ranked #563.

LPL Financial first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $141M in Q1 2026. 2,281 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • LPL Financial held 969,813 shares of Gilead Sciences worth $123M as of Q2 2026.
  • LPL Financial sold 41,751 Gilead Sciences shares in Q2 2026, an estimated $5.5M.
  • Gilead Sciences made up 0.03% of LPL Financial's portfolio in Q2 2026, its #563 holding.
  • LPL Financial first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • LPL Financial's Gilead Sciences position peaked at $141M in Q1 2026.
  • 2,281 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.